Authors:
Li, HF
Gildehaus, FJ
Dresel, S
Patt, JT
Shen, MH
Zhu, T
Liu, B
Tang, ZG
Tatsch, K
Hahn, K
Citation: Hf. Li et al., Comparison of in vivo dopamine D2 receptor binding of [I-123]AIBZM and [I-123]IBZM in rat brain, NUCL MED BI, 28(4), 2001, pp. 383-389
Authors:
Tiling, R
Linke, R
Untch, M
Richter, A
Fieber, S
Brinkbaumer, K
Tatsch, K
Hahn, K
Citation: R. Tiling et al., F-18-FDG PET and Tc-99m-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative study, EUR J NUCL, 28(6), 2001, pp. 711-720
Authors:
Chouker, M
Tatsch, K
Linke, R
Pogarell, O
Hahn, K
Schwarz, J
Citation: M. Chouker et al., Striatal dopamine transporter binding in early to moderately advanced Parkinson's disease: monitoring of disease progression over 2 years, NUCL MED C, 22(6), 2001, pp. 721-725
Authors:
Weil, S
Noachtar, S
Arnold, S
Yousry, TA
Winkler, PA
Tatsch, K
Citation: S. Weil et al., Ictal ECD-SPECT differentiates between temporal and extratemporal epilepsy: confirmation by excellent postoperative seizure control, NUCL MED C, 22(2), 2001, pp. 233-237
Authors:
Eisensehr, I
Wetter, TC
Linke, R
Noachtar, S
Von Lindeiner, H
Gildehaus, FJ
Trenkwalder, C
Tatsch, K
Citation: I. Eisensehr et al., Normal IPT and IBZM SPECT in drug-naive and levodopa-treated idiopathic restless legs syndrome, NEUROLOGY, 57(7), 2001, pp. 1307-1309
Authors:
Bartenstein, P
Grunwald, F
Kuwert, T
Tatsch, K
Sabri, O
Benkert, O
Fahlbusch, R
Grunder, G
Herholz, K
Weiller, C
Citation: P. Bartenstein et al., Clinical applications of single photon emission tomography in neuromedicine - Part 2: dementia, psychotic disorders, inflammation, trauma, NUKLEARMED, 39(8), 2000, pp. 218-232
Authors:
Bartenstein, P
Grunwald, F
Kuwert, T
Tatsch, K
Sabri, O
Benkert, O
Fahlbusch, R
Grunder, G
Herzholz, K
Weiller, C
Citation: P. Bartenstein et al., Clinical applications of single photon emission tomography in neuromedicine Part 1: Neuro-oncology, epilepsy, movement disorders, cerebrovascular disease, NUKLEARMED, 39(7), 2000, pp. 180-195
Authors:
Weiss, M
Konz, B
Schmid-Wendtner, MH
Sander, C
Dresel, S
Tatsch, K
Volkenandt, M
Hahn, K
Citation: M. Weiss et al., Metastases in patients with malignant melanoma despite of negative sentinel lymph node: Has the concept to be changed?, NUKLEARMED, 39(7), 2000, pp. 214-217
Authors:
Berger, F
Meyer, G
Weiss, M
Pfluger, T
Horn, K
Tatsch, K
Hahn, K
Citation: F. Berger et al., Somatostatin- and dopamin D2 receptor imaging in the diagnostik work-up ofa TSH-producing pituitary adenoma associated with "Empty Sella", NUKLEARMED, 39(1), 2000, pp. 31-34
Authors:
Arnold, S
Noachtar, S
Linke, R
Werhahn, KJ
Yousry, TA
Winkler, PA
Tatsch, K
Citation: S. Arnold et al., Ictal SPECT hyperperfusion reflects the activation of the symptomatogenic cortex in spontaneous and electrically-induced non-habitual focal epilepticseizures: correlation with subdural EEG recordings, EPILEPT DIS, 2(1), 2000, pp. 41-44
Authors:
Meier, M
Muhr, D
Weiss, M
Tatsch, K
Standl, E
Schnell, O
Citation: M. Meier et al., QTc interval and scintigraphically assessed myocardial perfusion in newly diagnosed and long-term type 1 diabetes mellitus, J DIABET C, 14(2), 2000, pp. 90-95
Citation: M. Soyka et al., FDG-PET and IBZM-SPECT suggest reduced thalamic activity but no dopaminergic dysfunction in chronic alcohol hallucinosis, J NEUROP CL, 12(2), 2000, pp. 287-288
Authors:
Benamer, HTS
Patterson, J
Grosset, DG
Booij, J
de Bruin, K
van Royen, E
Speelman, JD
Horstink, MHIM
Sips, HJWA
Dierckx, RA
Versijpt, J
Decoo, D
Van der Linden, C
Hadley, DM
Doder, M
Lees, AJ
Costa, DC
Gacinovic, S
Oertel, WH
Pogarell, O
Hoeffken, H
Joseph, K
Tatsch, K
Schwarz, J
Ries, V
Citation: Hts. Benamer et al., Accurate differentiation of parkinsonism and essential tremor using visualassessment of [I-123]-FP-CIT SPECT imaging: The [I-123]-FP-CIT study group, MOVEMENT D, 15(3), 2000, pp. 503-510
Citation: R. Linke et al., [I-123]IPT binding to the presynaptic dopamine transporter: variation of intra- and interobserver data evaluation in parkinsonian patients and controls, EUR J NUCL, 27(12), 2000, pp. 1809-1812
Authors:
Dresel, S
Krause, J
Krause, KH
LaFougere, C
Brinkbaumer, K
Kung, HF
Hahn, K
Tatsch, K
Citation: S. Dresel et al., Attention deficit hyperactivity disorder: binding of [(TC)-T-99m]TRODAT-1 to the dopamine transporter before and after methylphenidate treatment, EUR J NUCL, 27(10), 2000, pp. 1518-1524
Authors:
Krause, KH
Dresel, SH
Krause, J
Kung, HF
Tatsch, K
Citation: Kh. Krause et al., Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography, NEUROSCI L, 285(2), 2000, pp. 107-110
Authors:
Meisenzahl, EM
Dresel, S
Frodl, T
Schmitt, GJE
Preuss, UW
Rossmuller, B
Tatsch, K
Mager, T
Hahn, K
Moller, HJ
Citation: Em. Meisenzahl et al., D-2 receptor occupancy under recommended and high doses of olanzapine: an iodine-123-iodobenzamide SPECT study, J PSYCHOPH, 14(4), 2000, pp. 364-370
Citation: Pe. Radau et al., Optimization of automated quantification of I-123-IBZM uptake in the striatum applied to parkinsonism, J NUCL MED, 41(2), 2000, pp. 220-227
Authors:
Moog, F
Linke, R
Manthey, N
Tiling, R
Knesewitsch, P
Tatsch, K
Hahn, K
Citation: F. Moog et al., Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma, J NUCL MED, 41(12), 2000, pp. 1989-1995
Authors:
Eisensehr, I
Linke, R
Noachtar, S
Schwarz, J
Gildehaus, FJ
Tatsch, K
Citation: I. Eisensehr et al., Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder - Comparison with Parkinson's disease and controls, BRAIN, 123, 2000, pp. 1155-1160
Authors:
Schwarz, J
Linke, R
Kerner, M
Mozley, PD
Trenkwalder, C
Gasser, T
Tatsch, K
Citation: J. Schwarz et al., Striatal dopamine transporter binding assessed by [I-123]IPT and single photon emission computed tomography in patients with early Parkinson's disease - Implications for a preclinical diagnosis, ARCH NEUROL, 57(2), 2000, pp. 205-208